HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiotensin-(1-7) antagonist [D-Ala7-Ang-(1-7);A-779] attenuates post-suspension hypotension in Sprague-Dawley rats.

Abstract
Cardiovascular deconditioning manifested by reduction in mean arterial pressure (MAP) and cardioaccleration are usually observed in astronauts during standing postflight. The head-down tilt (HDT) rat model with "unloaded" hindlimbs has been extensively studied because some of the observed responses mimic observations made during exposure to microgravity. Angiotensin-(1-7) is a biologically active component of the renin-angiotensin system that acts to oppose the pressor and proliferative actions of Angiotensin II. It produces a hypotensive response by either stimulating production of vasodilator prostaglandins (i.e., prostacyclin), increasing nitric oxide or both. In the present study, we have evaluated the role of a specific inhibitor of Ang-(1-7), D-Ala7-Ang-(1-7)[A-779], as a countermeasure against post-suspension hypotension.
AuthorsM A Bayorh, M Wang, R R Socci, D Eatman, N Emmett, M Thierry-Palmer
JournalJournal of gravitational physiology : a journal of the International Society for Gravitational Physiology (J Gravit Physiol) Vol. 6 Issue 1 Pg. P115-6 (Jul 1999) ISSN: 1077-9248 [Print] United States
PMID11542983 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • 7-Ala-angiotensin (1-7)
  • Peptide Fragments
  • Angiotensin II
Topics
  • Angiotensin II (analogs & derivatives, pharmacology)
  • Animals
  • Blood Pressure (drug effects)
  • Heart Rate
  • Hindlimb Suspension
  • Hypotension, Orthostatic (prevention & control)
  • Male
  • Peptide Fragments (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Weightlessness Countermeasures
  • Weightlessness Simulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: